Skip to main content
SpringerLink
Log in

Psychopharmacologic Agents and Electroconvulsive Therapy during Pregnancy and the Puerperium

  • Chapter
Psychiatric Consultation in Childbirth Settings

Abstract

The treatment of pregnant and lactating women with psychopharmacologic agents requires skilled decision making on the part of the psychiatric consultant. The physician must consider the benefits of pharmacotherapy compared to the risks it involves not only for the mother but also for the developing fetus. In assigning weights to the factors that enter the risk/benefit equation, the physician must be aware of data from the literature regarding medication administration during pregnancy. The objective of this chapter is to provide an overview of currently available data with respect to pharmacologic treatment during pregnancy and lactation for the major classes of medications used in psychiatric practice: antipsychotics, antidepressants, lithium, and antianxiety agents. Information on the use of electroconvulsive therapy (ECT) during pregnancy will also be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cupit GC, Rotmensch HH: Principles of drug therapy in pregnancy, in Gleicher N (ed): Principles of Medical Therapy in Pregnancy. New York, Plenum Press, 1985, pp 77–90.

    Google Scholar 

  2. Levy GH: Pharmacokinetics of fetal and neonatal exposure to drugs. Obstet Gynecol 58 (Suppl): 9S–16S, 1981.

    PubMed  CAS  Google Scholar 

  3. Mirkin BL: Drug disposition and therapy in the developing human being. Pediatr Ann 5: 542–557, 1976.

    PubMed  CAS  Google Scholar 

  4. Chao ST, Juchau MR: Placental drug metabolism, in Johnson EM, Kochhar DM (eds), Teratogenesis and Reproductive Toxicology. New York, Springer-Verlag, 1983, pp 31–48.

    Google Scholar 

  5. Soyka LF, Bigelow SW: Drug-metabolizing enzymes and their activity in the human fetus, in Stern L (ed): Drug Use in Pregnancy. Sydney, Australia, Adis Health Science Press, 1984, pp 17–44.

    Google Scholar 

  6. Finster M, Mark LC: Placental transfer of drugs and their distribution in fetal tissue, in Brodie BB, Gillette JR (ed): Basic Concepts in Biochemical Pharmacology. New York, Springer-Verlag, Berlin/Heidelberg, 1971, pp 276–285.

    Google Scholar 

  7. American Medical Association: Drug interactions and adverse drug reactions, in: AMA Drug Evaluations. Chicago, 1983, pp 31–44.

    Google Scholar 

  8. Wilson JG: Current status of teratology. General principles and mechanisms derived from animal studies, in Wilson JG, Fräser FC (eds): Handbook of Teratology, General Principles and Etiology, Vol. 1. New York, Plenum Press, 1977, pp 47–74.

    Google Scholar 

  9. Vorhees CV, Butcher, RE: Behavioral teratogenicity, in Snell K (ed): Developmental Toxicology. New York, Praeger, 1982, pp 249–298.

    Google Scholar 

  10. Werboff J, Gottlieb JS: Drugs in pregnancy: Behavioral teratology. Obstet Gynaec Survey 18: 420–423, 1963.

    Google Scholar 

  11. Coyle I, Wayner MJ, Singer G: Behavioral teratogenesis: A critical evaluation. Pharmac Biochem Behav 4: 191–200, 1976, 1976.

    Google Scholar 

  12. Hutchings DE: Behavioral teratology: A new frontier in neurobehavioral research, in Johnson EM, Kochhar DM (eds): Teratogenesis and Reproductive Toxicology. New York, Springer-Verlag, 1983, pp 207–235.

    Google Scholar 

  13. Brent RL: Methods of evaluating the alleged teratogenicity of environmental agents, in: Prevention of Physical and Mental Congenital Defects, Part C: Basic and Medical Science, Education, and Future Strategies. New York, Alan R. Liss, 1985, pp 191–195.

    Google Scholar 

  14. Cordero JF, Oakley GP: Drug exposure during pregnancy: Some epidemiologic considerations. Clin Obstet Gynecol 26: 418–428, 1983.

    PubMed  CAS  Google Scholar 

  15. Bracken MB: Methodological issues in the epidemiologic investigation of drug-induced congenital malformations, in Bracken MB (ed): Perinatal Epidemiology. New York, Oxford University Press, 1984, pp 423–449.

    Google Scholar 

  16. FDA Drug Bulletin, Sept., pp 22–23, 1979.

    Google Scholar 

  17. Briggs GG, Bodendorfer TW, Freeman RK, et al: Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore, Williams amp; Wilkins, 1983.

    Google Scholar 

  18. Gutheil TG: Improving patient compliance: Psychodynamics in drug prescribing. Drug Ther Hosp, July, pp 35–40, 1977.

    Google Scholar 

  19. Mogul KM: Psychological considerations in the use of psychotropic drugs with women patients. Hosp Comm Psychiatry 36: 1080–1085, 1985.

    CAS  Google Scholar 

  20. Hillard JR, Hillard PJA: Early diagnosis of pregnancy in a patient receiving antipsychotic medication. Am J Psychiatry 138: 9–10, 1981.

    Google Scholar 

  21. Davis JM, Janicak P, Chang S, et al: Recent advances in the pharmacologic treatment of the schizophrenic disorders, in Grinspoon L (ed): Psychiatry Update. The American Psychiatric Association Annual Review. Washington, D.C., American Psychiatric Press, 1982, pp 178–228.

    Google Scholar 

  22. Edlund MJ, Craig TJ: Antipsychotic drug use and birth defects: An epidemiologic reassessment. Corripr Psychiatry 25: 32–37, 1984.

    CAS  Google Scholar 

  23. Milkovich L, van den Berg BJ: An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 125: 244–248, 1976.

    PubMed  CAS  Google Scholar 

  24. Kris EB: Children born to mothers maintained on pharmacotherapy during pregnancy and postpartum. Recent Adv Biol Psychiatr 4: 180–187, 1961.

    CAS  Google Scholar 

  25. Kris EB: Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Curr Ther Res 7: 785–789, 1965.

    PubMed  CAS  Google Scholar 

  26. Sobel DE: Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine. Arch Gen Psychiatry 2: 606–611, 1960.

    CAS  Google Scholar 

  27. Slone D, Siskind V, Heinonen OP: Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 128: 486–488, 1977.

    PubMed  CAS  Google Scholar 

  28. Rumeau-Rouquette C, Goujard J, Huel G: Possible teratogenic effect of phenothiazines in human beings. Teratology 15: 57–64, 1976.

    Google Scholar 

  29. Hall G: A case of phocomelia of the upper limbs. Med J Aust 1: 449–450, 1963.

    Google Scholar 

  30. Moriarty AJ, Nance MR: Trifluoperazine and pregnancy. Med J Aust 88: 375–376, 1963.

    CAS  Google Scholar 

  31. Rawlings WJ, Ferguson F, Maddison TG: Phenmetrazine and trifluoperazine. Med J Aust 1: 370, 1963.

    Google Scholar 

  32. Heinonen OP, Slone D, Shapiro S: Birth Defects in Pregnancy. Littleton, Publishing Sciences Group, 1977.

    Google Scholar 

  33. Scanlan FJ: The use of thioridazine (Melleril) [sic] during the first trimester. Med J Aust 1: 1271–1272, 1972.

    PubMed  CAS  Google Scholar 

  34. Cleary MF: Fluphenazine decanoate during pregnancy. Am J Psychiatry 134: 815–816, 1977.

    PubMed  CAS  Google Scholar 

  35. Donaldson GL, Bury RG: Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy. Acta Paediatr Scand 71: 335–338, 1982.

    PubMed  CAS  Google Scholar 

  36. Kopelman AE, McCullar FW: Limb malformations following maternal use of haloperidol. JAMA 231: 62–64, 1975.

    Google Scholar 

  37. Hanson JW, Oakley GP: Haloperidol and limb deformity. JAMA 231: 26, 1975.

    PubMed  CAS  Google Scholar 

  38. van Waes A, van de Velde E: Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Pharmacol 9: 224–227, 1969.

    Google Scholar 

  39. Donaldson JO: Control of chorea gravidarum with haloperidol. Obstet Gynecol 59: 381–382, 1982.

    PubMed  CAS  Google Scholar 

  40. Patterson JF: Treatment of chorea gravidarum with haloperidol. Southern Med J 72: 1220–1221, 1979.

    PubMed  CAS  Google Scholar 

  41. Hammond JE, Toseland PA: Placental transfer of chlorpromazine. Arch Dis Child 45: 139–140, 1970.

    PubMed  CAS  Google Scholar 

  42. Scokel PW, Jones WN: Infant jaundice after phenothiazine drugs for labor: An enigma. Obstet Gynecol 20: 124–127, 1962.

    PubMed  CAS  Google Scholar 

  43. Falterman CG, Richardson J: Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J Pediatr 97: 308–310, 1980.

    CAS  Google Scholar 

  44. Levy W, Wisniewski K: Chlorpromazine causing extrapyramidal dysfunction. NY State J Med 74: 684–685, 1974.

    CAS  Google Scholar 

  45. O’Connor M, Johnson GH, James DI: Intrauterine effect of phenothiazines. Med J Aust 1: 416–417, 1981.

    PubMed  Google Scholar 

  46. Hill RM, Desmond MM, Kay JJ: Extrapyramidal dysfunction in an infant of a schizophrenic mother. J Pediatr 69: 589–595, 1966.

    PubMed  CAS  Google Scholar 

  47. Desmond M, Rudolph AJ, Hill RM, et al: Behavioral alterations in infants born to mothers on psychoactive medication during pregnancy, in Farrell G (ed): Congenital Mental Retardation. Austin, Univ of Texas Press, 1969, pp 235–241.

    Google Scholar 

  48. Madsen JR, Campbell A, Baldessarini RJ: Effects of prenatal treatment of rats with haloperidol due to altered drug distribution in neonatal brain. Neuropharmacology 20: 931–939, 1981.

    PubMed  CAS  Google Scholar 

  49. Whalley LJ, Blain PG, Prime JK: Haloperidol secreted in breast milk. Br Med J 282: 1746–1747, 1981.

    CAS  Google Scholar 

  50. Stewart RB, Karas B, Springer PK: Haloperidol excretion in human milk. Am J Psychiatry 137: 849–850, 1980.

    PubMed  CAS  Google Scholar 

  51. Kris EB, Carmichael DM: Chlorpromazine maintenance therapy during pregnancy and confinement. Psychiatric Q 31: 690–695, 1957.

    CAS  Google Scholar 

  52. Herson MH, Barlow DH: Single Case Experimental Designs. Strategies for Studying Behavioral Change. New York, Pergamon Press, 1976.

    Google Scholar 

  53. Brown WA: Psychological Care during Pregnancy and the Postpartum Period. New York, Raven Press, 1979.

    Google Scholar 

  54. Kargas GA, Kargas SA, Bruyere HJ Jr, et al: Perinatal mortality due to interaction of dephenhydramine and temazepam, letter to editor. N Engl J Med 313: 14–17, 1985.

    Google Scholar 

  55. Saxen I: Cleft palate and maternal dephenhydramine intake. The Lancet 1: 407–408, 1974.

    CAS  Google Scholar 

  56. Parkin DE: Probable benadryl withdrawal manifestations in a newborn infant. J Pediatr 85: 580, 1974.

    PubMed  CAS  Google Scholar 

  57. O’Brien TE: Excretion of drugs in human milk. Am J Hosp Pharm 31: 844–854, 1974.

    PubMed  Google Scholar 

  58. Cole JO, Schatzberg AF: Antidepressant drug therapy, in Grinspoon L (ed): Psychiatry Update. The American Psychiatric Association Annual Review. Washington, D.C., American Psychiatric Press, 1983, pp 472–490.

    Google Scholar 

  59. Perel JM: Tricyclic antidepressant plasma levels, pharmacokinetics, and clinical outcome, in Grinspoon L (ed): Psychiatry Update. The American Psychiatric Association Annual Review. Washington, D.C., American Psychiatric Press, 1983, pp 490–511.

    Google Scholar 

  60. Edwards JG: Antidepressants and convulsions. The Lancet, December 22 /29, 1979, pp 1368–1369.

    Google Scholar 

  61. McBride WG: Limb deformities associated with iminodibenzyl hydrochloride. Med J Aust 1: 492, 1972.

    PubMed  CAS  Google Scholar 

  62. Australian Drug Evaluation Committee, Tricyclic antidepressants and limb reduction deformities. Med J Aust 1: 768–769, 1973.

    Google Scholar 

  63. Morrow AW: Limb deformities associated with iminodebenzyl hydrochloride. Med J Aust 1: 658–659, 1972.

    PubMed  CAS  Google Scholar 

  64. Crombie DL, Pinsent RJ, Fleming D: Imipramine in pregnancy. Br Med J 1: 745, 1972.

    PubMed  CAS  Google Scholar 

  65. Kuenssberg EV, Knox JDE: Imipramine in pregnancy. Br Med J 2: 292, 1972.

    PubMed  CAS  Google Scholar 

  66. Scanion FJ: Use of antidepressant drugs during the first trimester. Med J Aust 2: 1077, 1969.

    Google Scholar 

  67. Sim M: Imipramine and pregnancy. Br Med J 2: 745, 1972.

    Google Scholar 

  68. Rachelefsky GS, Flynt JW Jr, Ebbin A, et al: Possible teratogenicity of tricyclic antidepressants. The Lancet 1: 838, 1972.

    Google Scholar 

  69. Banister P, DeFoe C, Smith ESO, et al: Possible teratogenicity of tricyclic antidepressants. The Lancet 1: 838–839, 1972.

    Google Scholar 

  70. Bracken MB, Holford TR: Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol 58: 336–343, 1981.

    PubMed  CAS  Google Scholar 

  71. Eggermont E, Raveschat J, Deneve V, et al: The adverse influence of imipramine on the adaption of the newborn infant to extrauterine life. Acta Paediatr Belg 26: 197–204, 1972.

    PubMed  CAS  Google Scholar 

  72. Webster PAC: Withdrawal symptoms in neonates associated with maternal antidepressant therapy. The Lancet 2: 318–319, 1973.

    CAS  Google Scholar 

  73. Gualtieri CT, Staye J: Withdrawal symptoms after abrupt cessation of amitriptyline in an 8-year-old boy. Am J Psychiatry 136: 457–458, 1979.

    CAS  Google Scholar 

  74. Petti TA, Law W: Abrupt cessation of high-dose imipramine treatment in children. JAMA 246: 768–769, 1981.

    PubMed  CAS  Google Scholar 

  75. Law W, Petti TA, Kazdin AE: Withdrawal symptoms after graduated cessation of imipramine in children. Am J Psychiatry 138: 647–650, 1981.

    PubMed  Google Scholar 

  76. Dilsaver SC, Kronfol Z, Sackellares JC, et al: Antidepressant withdrawal syndromes: Evidence supporting the cholinergic overdrive hypothesis. J Clin Psychopharmacology 3: 157–164, 1983.

    CAS  Google Scholar 

  77. Shearer WT, Schreiner RL, Marshall RE: Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J Pediatr 81: 570–572, 1972.

    PubMed  CAS  Google Scholar 

  78. Sjoqvist F, Bergfors PG, Borga O, et al: Plasma disappearance of nortriptyline in a newborn infant following placental transfer from an intoxicated mother: Evidence for drug metabolism. J Pediatr 80: 496–500, 1972.

    PubMed  CAS  Google Scholar 

  79. Sovner R, Orsulak PJ: Excretion of imipramine and desipramine in human breast milk. Am J Psychiatry 136: 451–452, 1979.

    PubMed  CAS  Google Scholar 

  80. Erickson SH, Smith GH, Heidrich F: Tricyclics and breast-feeding. Letters to the editor. Am J Psychiatry 136: 1483, 1979.

    PubMed  CAS  Google Scholar 

  81. Orsulak R, Sovner PJ: Drs. Orsulak and Sovner reply. Letters to the editor. Am J Psychiatry 136: 1483, 1979.

    Google Scholar 

  82. Bader TF, Newman K: Amitriptyline in human breast milk and the nursing infant’s serum. Am J Psychiatry 137: 855–856, 1980.

    PubMed  CAS  Google Scholar 

  83. Ananth J: The effects in the neonate from psychotropic agents excreted through breastfeeding. Am J Psychiatry 135: 801–805, 1978.

    PubMed  CAS  Google Scholar 

  84. Brixen-Rasmussen L, Halgrener J, Jorgensen A: Amitriptyline and nortriptyline excretion in human breast milk. Psychopharmacology 76: 94–95, 1982.

    PubMed  CAS  Google Scholar 

  85. Verbeeck RK, Ross SG, McKenna EA: Excretion of trazodone in breast milk. Br J Clin Pharmacol 22: 367–370, 1986.

    PubMed  CAS  Google Scholar 

  86. Kane FJ: Postpartum disorders, in Kaplan HI, Sadock BJ (eds): Comprehensive Textbook of Psychiatry IV. Baltimore, Williams amp; Wilkins, 1985, pp 1238–1242.

    Google Scholar 

  87. Hamilton JA: Guidelines for therapeutic management of postpartum disorders, in Inwood DG: Recent Advances in Postpartum Psychiatric Disorders. Washington, D.C., American Psychiatric Press, 1985, pp 83–96.

    Google Scholar 

  88. Oates M: The role of electroconvulsive therapy in the treatment of postnatal mental illness, in Cox JL, Kumar R, Margison FR et al: Current Approaches. Puerperal Mental Illness. Southampton, England, Duphar Laboratories Limited, 1986, pp 1–12.

    Google Scholar 

  89. Frank E, Kupfer DG, Jacob M, et al: Pregnancy-related affective episodes among women with recurrent depression. Am J Psychiatry 144: 288–293, 1987.

    PubMed  CAS  Google Scholar 

  90. Schou M, Amdisen A, Streenstrup OR: Lithium and pregnancy—II, Hazards to women given lithium during pregnancy and delivery. Br Med J 2: 137–138, 1973.

    PubMed  CAS  Google Scholar 

  91. Weinstein MR: Lithium treatment of women during pregnancy and in the post-delivery period, in Johnson FN (ed): Handbook of Lithium Therapy. Lancaster, England, MTP Press, 1980, pp 421–429.

    Google Scholar 

  92. Schou M: Practical problems of lithium maintenance treatment, in Kemali D, Racagni G (eds): Chronic Treatments in Neuropsychiatry. New York, Raven Press, 1985, pp 131–138.

    Google Scholar 

  93. Calabrese JR, Gulledge AD: Psychotropics during pregnancy and lactation: A review. Psychosomatics 26: 413–426, 1985.

    PubMed  CAS  Google Scholar 

  94. Linden S, Rich CL,. The use of lithium during pregnancy and lactation. J Clin Psychiatry 44: 358–361, 1983.

    PubMed  CAS  Google Scholar 

  95. Nora JJ, Nora AH, Towes WH., Lithium,Ebstein’s anomaly, and other congenital heart defects. The Lancet 2: 594–595, 1974.

    CAS  Google Scholar 

  96. Weinstein MR, Goldfield MD: Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 132: 529–531, 1975.

    PubMed  CAS  Google Scholar 

  97. Behrman RE, Vaughan VC (eds): Nelson’s Textbook of Pediatrics. Philadelphia, WB Saunders, 1983, pp 1136–1137.

    Google Scholar 

  98. Giuliani ER, Fuster V, Brandenburg RO, et al: Ebstein’s anomaly: The clinical features and natural history of Ebstein’s anomaly of the tricuspid valve. Mayo Clin Proc 54: 163–173, 1970.

    Google Scholar 

  99. Danielson GK, Fuster V: Surgical repair of Ebstein’s anomaly. Ann Surg 196: 499–503, 1982.

    PubMed  CAS  Google Scholar 

  100. Anderson KR, Zuberbuhler JR, Anderson RH, et al: Morphologic spectrum of Ebstein’s anomaly of the heart: A review. Mayo Clin Proc 54: 174–180, 1979.

    PubMed  CAS  Google Scholar 

  101. Wilson JG, Fräser FC (eds): Handbook of Teratology, General Principles and Etiology. New York, Plenum Press, 1977.

    Google Scholar 

  102. Long WA, Willis PW,: Maternal lithium and neonatal Ebstein’s anomaly: Evaluation with cross-sectional echocardiography. Am J Perinatol 1: 182–184, 1984.

    PubMed  CAS  Google Scholar 

  103. Allan LD, Desai G, Tynan MJ: Prenatal echocardiography screening for Ebstein’s anomaly for mothers on lithium therapy. The Lancet, October 16, 1982, pp 875–876.

    Google Scholar 

  104. Kallen B, Tandberg A: Lithium and pregnancy. A cohort study on manic-depressive women. Acta Psychiatr Scand 68: 134–139, 1983.

    PubMed  CAS  Google Scholar 

  105. Schou M: What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 54: 193–197, 1976.

    PubMed  CAS  Google Scholar 

  106. Goodwin FK: Treatment of bipolar disorders, in Hales RE, Frances AJ (eds): Psychiatry Update. The American Psychiatric Association Annual Review. Washington, D.C., American Psychiatric Press, 1987, pp 81–107.

    Google Scholar 

  107. Jamison KR: Psychotherapeutic issues and suicide prevention in the treatment of bipolar disorders, in Hales RE, Frances AJ (eds): Psychiatry Update. The American Psychiatric Association Annual Review. Washington, D.C., American Psychiatric Press, 1987, pp 108–124.

    Google Scholar 

  108. Consensus Development Panel: Mood disorders: pharmacologic prevention of recurrences. NIMH/NIH consensus development panel statement. Am J Psychiatry 142: 469–476, 1985.

    Google Scholar 

  109. Gelenberg AJ: When a woman taking lithium wants to have a baby. Biol Ther Psychiatr 6: 19–20, 1983.

    Google Scholar 

  110. Morrell P, Sutherland GR, Buamah PK, et al: Lithium toxicity in a neonate. Arch Dis Child 58: 538–539, 1983.

    Google Scholar 

  111. Karlsson K, Lindstedt G, Lundberg PA, et al: Transplacental lithium poisoning: Reversible inhibition of fetal thyroid. The Lancet 1: 1295, 1975.

    CAS  Google Scholar 

  112. Stevens D, Burman D, Midwinter A: Transplacental lithium poisoning: Reversible inhibition of fetal thyroid. The Lancet 1: 1295, 1974.

    Google Scholar 

  113. Wilson N, Forfar JC, Godman MJ: Atrial flutter in the newborn resulting from maternal lithium ingestion. Arch Dis Child 58: 538–549, 1983.

    PubMed  CAS  Google Scholar 

  114. Mizrahi EM, Hobbs JF, Goldsmith DI: Nephrogenic diabetes insipidus in transplacental lithium intoxication. J Pediatr 94: 493–495, 1979.

    PubMed  CAS  Google Scholar 

  115. MacKay AVP, Loose R, Glen AIM: Labour on lithium. Br Med J, April 10, 1976, p 878.

    Google Scholar 

  116. Tunnessen WW Jr, Hertz CG: Toxic effects of lithium in newborn infants: A commentary. J Pediatr 81: 804–807, 1972.

    PubMed  Google Scholar 

  117. Sykes PA, Quarrie J, Alexander FW: Lithium carbonate and breast-feeding. Br Med J 2: 1299, 1976.

    PubMed  CAS  Google Scholar 

  118. Schou M, Amdisen A: Lithium and pregnancy—III, Lithium ingestion by children breast-fed by women on lithium treatment. Br Med J 2: 138, 1973.

    PubMed  CAS  Google Scholar 

  119. Berlin CM: Pharmacologic considerations of drug use in the lactating mother. Obstet Gynecol 58 (Suppl): 17S–23S, 1981.

    PubMed  Google Scholar 

  120. Targum SD, Davenport VB, Webster MJ: Postpartum mania in bipolar manic-depressive patients withdrawn from lithium carbonate. J Nerv Ment Dis 167: 572–574, 1979.

    PubMed  CAS  Google Scholar 

  121. Post RM, Uhde TW: Clinical approaches to treatment resistant bipolar illness, in Hales RE, Frances AJ (eds): Psychiatry Update. American Psychiatric Association Annual Review. Washington, D.C., American Psychiatric Press, 1987, pp 125–150.

    Google Scholar 

  122. NIH Consensus Conference: Electroconvulsive therapy. JAMA 254: 2103–2108, 1985.

    Google Scholar 

  123. Repke JT, Berger NG: Electroconvulsive therapy in pregnancy. Obstet Gynecol 63 (Suppl): 39S–41S, 1984.

    PubMed  CAS  Google Scholar 

  124. Varan LR, Gillieson MS, Skene DS, et al: ECT in an acutely psychotic pregnant woman with actively aggressive (homicidal) impulses. Can J Psychiatry 30: 363–367, 1985.

    PubMed  CAS  Google Scholar 

  125. Wise MG, Ward SC, Townsend-Parchman W, Gilstrap LC, et al: Case report of ECT during high-risk pregnancy. Am J Psychiatry 141: 99–101, 1984.

    PubMed  CAS  Google Scholar 

  126. Levine R, Frost EAM: Arterial blood-gas analyses during electroconvulsive therapy in a parturient. Anesth Analg 54: 203–205, 1975.

    PubMed  CAS  Google Scholar 

  127. Impastato DJ, Gabriel AR, Lardara HH: Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 25: 542–546, 1964.

    PubMed  CAS  Google Scholar 

  128. Sobel DE: Fetal damage due to ECT insulin coma, chlorpromazine and reserpine. Arch Gen Psych 2: 603–611, 1960.

    Google Scholar 

  129. Fink M: Convulsive and drug therapies of depression. Ann Rev Med 32: 405–412, 1981.

    PubMed  CAS  Google Scholar 

  130. Ostheimer G, Warren TM: Obstetric analgesia and anesthesia, in Stern L (ed): Drug Use in Pregnancy. Sydney, Australia, Adis Health Science Press, 1984, pp 216–269.

    Google Scholar 

  131. Remick RA, Maruice WL: ECT in pregnancy. Am J Psychiatry 135: 761–762, 1978.

    PubMed  CAS  Google Scholar 

  132. Foldes FF: Enzymes of acetylcholine metabolism, in Foldes FF (ed): Enzymes in Anesthesiology. New York, Springer-Verlag, 1978, pp 101–144.

    Google Scholar 

  133. Kalow W, Gunn DR: The relation between dose of succinylcholine and duration of apnea in man. J Pharmacol Exper Ther 120: 203–214, 1957.

    CAS  Google Scholar 

  134. Weis WF, Muller FO, Lyell H, et al: Materno-fetal Cholinesterase inhibitor poisoning. Anesth Analg 62: 233–235, 1983.

    PubMed  CAS  Google Scholar 

  135. Moya F, Kvisselgaard N: The placental transmission of succinylcholine. Anesthesiology 22: 1–10, 1961.

    PubMed  CAS  Google Scholar 

  136. Owens WD, Zeitlin GL: Hypoventilation in a newborn following administration of succinylcholine to the mother. Anesth Analg 54: 38–39, 1975.

    PubMed  CAS  Google Scholar 

  137. Zbella EA, Gleicher N: Disorders of metal and metalloproteins, in Gleicher N (ed): Principles of Medical Therapy in Pregnancy. New York, Plenum, Press, 1985.

    Google Scholar 

  138. Brodie MJ, Moore MR, Thompson GG, et al: Pregnancy and the acute porphyrias. Br J Obstet Gynecol 84: 726–731, 1977.

    CAS  Google Scholar 

  139. Forssman H: Follow-up study of sixteen children whose mothers were given electric convulsive therapy during gestation. Acta Psychiatr Neurol Scand 30: 437–441, 1955.

    PubMed  CAS  Google Scholar 

  140. Brockington IF, Winokur G, Dean C: Puerperal psychosis, in Brockington IF, Kumar R (eds): Motherhood and Mental Illness. London, Academic Press, 1980, pp 37–69.

    Google Scholar 

  141. Frank JD: The psychotherapy of anxiety, in: Psychiatry Update. American Psychiatric Association Annual Review. Washington, DC, American Psychiatric Press, 1984, pp 418–426.

    Google Scholar 

  142. Benson H: The relaxation response and the treatment of anxiety, in: Psychiatry Update. American Psychiatric Association Annual Review. Washington, DC, American Psychiatric Press, 1984, pp 440–448.

    Google Scholar 

  143. Mavissakalian M: Exposure treatment of agoraphobia, in: Psychiatry Update. American Psychiatric Association Annual Review. Washington, DC, American Psychiatric Press, 1984, pp 448–460.

    Google Scholar 

  144. Kanto JH: Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations. Drugs 23: 354–380, 1982.

    PubMed  CAS  Google Scholar 

  145. Mandelli M, Morselli PL, Nordio S, et al: Placental transfer of diazepam and its disposition in the newborn. Clin Pharmacol Ther 17: 564–572, 1975.

    PubMed  CAS  Google Scholar 

  146. Moore RG, McBride WG: The disposition kinetics of diazepam in pregnant women at parturition. Europ J Clin Pharmacol 13: 275–284, 1978.

    CAS  Google Scholar 

  147. Byck R: Drugs and the treatment of psychiatric disorders, in Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics. New York, Macmillan Publishing Co, 1975, pp 152–299.

    Google Scholar 

  148. Kangas L, Erkkola R, Kanto J, et al: Transfer of free and conjugated oxazepam across the human placenta. Eur J Clin Pharmacol 17: 301–304, 1980.

    PubMed  CAS  Google Scholar 

  149. Whitelaw AGL, Cummings AJ, McFadyen IF: Effect of maternal lorazepam on the neonate. Br Med J 282: 1106–1108, 1981.

    CAS  Google Scholar 

  150. Hauri PJ, Sateia MJ: Nonpharmacological treatment of sleep disorders, in Hales RE, Frances AJ (eds): Psychiatry Update. American Psychiatric Association Annual Review. Washington, DC, American Psychiatric Press, 1985, pp 361–394.

    Google Scholar 

  151. Mendelson WB: Pharmacological treatment of insomnia, in Hales RE, Frances AJ (eds): Psychiatry Update. American Psychiatric Association Annual Review. Washington, D.C., American Psychiatric Press, 1985, pp 379–394.

    Google Scholar 

  152. Milkovich L, van den Berg BJ: Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Engl J Med 291: 1268–1271, 1974.

    PubMed  CAS  Google Scholar 

  153. Hartz SC, Heinonen OP, Shapiro S, Siskind V, Slone D: Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N Engl J Med 292: 726–728, 1975.

    PubMed  CAS  Google Scholar 

  154. Safra JM, Oakley GP: Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. The Lancet 2: 478–480, 1980.

    Google Scholar 

  155. Rosenberg L, Mitchell AA, Parsells JL, et al: Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 309: 1282–1285, 1983.

    PubMed  CAS  Google Scholar 

  156. deHaan J, Van Bemmel JH, Stolte LAM, et al: Quantitative evaluation of fetal heart rate patterns. Europ J Obstet Gynecol 3: 103–110, 1971.

    Google Scholar 

  157. Yeh SY, Paul RIT, Cordero L, et al: A study of diazepam during labor. Obstet Gynecol 43: 363–373, 1974.

    PubMed  CAS  Google Scholar 

  158. van Geijn HP, Jongsma HW, Doesburg WH, et al: The effect of diazepam administration during pregnancy or labor on the heart rate variability of the newborn infant. Eur J Obstet Gynecol Reprod Biol 10: 187–201, 1980.

    PubMed  Google Scholar 

  159. Cree JE, Meyer J, Hailey DM: Diazepam in labour: Its metabolism and effect on the clinical condition and thermogenesis of the newborn. Br Med J 4: 251–255, 1973.

    PubMed  CAS  Google Scholar 

  160. Gillberg C: “Floppy infant syndrome” and maternal diazepam. The Lancet 2:244, 1977.

    Google Scholar 

  161. Speight AN: Floppy-infant syndrome and maternal diazepam and/or nitrazepam. The Lancet 1: 878, 1977.

    Google Scholar 

  162. Volpe JJ: Teratogenic effects of drugs and passive addiction, in Volpe JJ (ed): Neurology of the Newborn. Philadelphia, WB Saunders Co., 1981, pp 601–635.

    Google Scholar 

  163. Rementeria JL, Bhatt K: Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 90: 123–126, 1977.

    PubMed  CAS  Google Scholar 

  164. Mazzi E: Possible neonatal diazepam withdrawal: A case report. Am J Obstet Gynecol 129: 586–587, 1977.

    PubMed  CAS  Google Scholar 

  165. Athinarayanan P, Pierog SH, Nigam S, et al: Chlordiazepoxide withdrawal in the neonate. Am J Obstet Gynecol 124: 212–213, 1976.

    PubMed  CAS  Google Scholar 

  166. Erkkola R, Kanto J: Diazepam and breast-feeding. The Lancet 2: 1235–1236, 1972.

    Google Scholar 

  167. Patrick MJ, Tilstone WJ, Reavey P: Diazepam and breast-feeding. The Lancet 1: 542–543, 1972.

    CAS  Google Scholar 

  168. Kumar R: Neurotic disorders in childbearing women, in Brockington IF, Kumar R (eds): Motherhood and Mental Illness. London, Academic Press, 1982, pp 71–118.

    Google Scholar 

  169. Perel JM, Glassman AH : unpublished data.

    Google Scholar 

  170. Nürnberg GH, Prudic J: Guidelines for treatment of psychosis during pregnancy. Hosp Comm Psych 35: 67–71, 1984.

    Google Scholar 

  171. Gelenberg A J: Pregnancy, psychotropic drugs, and psychiatric disorders. Psychosomatics 27: 216–217, 1986.

    PubMed  CAS  Google Scholar 

  172. Margison F, Brockington IF: Psychiatric mother and baby units, in Brockington IF, Kumar R (eds): Motherhood and Mental Illness. London, Academic Pretfs, 1982, pp 223–238.

    Google Scholar 

  173. Kaplan MM: Thyroid disease in pregnancy, in Gleicher N (ed): Principles of Medical Therapy in Pregnancy. New York, Plenum Press, 1985, pp 192–211.

    Google Scholar 

  174. Ziegler VE, Knesevich JW, Wylie LT, et al: Sampling time, dosage schedule, and nortriptyline plasma levels. Arch Gen Psychiatry 34: 613–615, 1977.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, 15213, USA

    Katherine L. Wisner

  2. Departments of Psychiatry and Pharmacology, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, 15213, USA

    James M. Perel

Authors
  1. Katherine L. Wisner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James M. Perel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Publishing Corporation

About this chapter

Cite this chapter

Wisner, K.L., Perel, J.M. (1988). Psychopharmacologic Agents and Electroconvulsive Therapy during Pregnancy and the Puerperium. In: Psychiatric Consultation in Childbirth Settings. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5439-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5439-0_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5441-3

  • Online ISBN: 978-1-4684-5439-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation